In 2018, University of Kentucky (UK) HealthCare reported 400 cases of endocarditis, of which 73% were injection drug use-associated infections. To curb overdose deaths, ease the financial burden on healthcare, and improve patient outcomes, researchers worked with patients who need tools for recovery from opioid use disorder, such as mental health therapists, relapse-prevention services, and necessary medications. Poverty, unemployment, and legal issues are barriers, as well as transportation to treatment for those who live in rural areas—an issue that researchers say came up frequently regarding their patients. Limited access to clinics due to COVID-19-related closings has been a challenge to treatment recently. Among referrals to the program thus far in the ongoing study, 69% were eligible, among whom 625 enrolled. Among them, 35% are receiving medication-assisted treatment and 14.8% are being managed by the UK Infectious Diseases division. Among patients with other service data available, 88% were dispensed naloxone, 47% received relapse prevention services, 25% engaged in peer support, 18% participated in self-help groups, and 20% received transportation aid. “This program shows proof of concept that patients can be engaged in MAT by ID providers,” write the study authors.
September 8, 2020
ACEP20: Despite Increased Stress Due to COVID-19, Nearly Half of ED Physicians Fear Seeking Mental Healthcare
October 30, 2020
September 16, 2020
October 4, 2019
- ACC 2020The American College of Cardiology decided to cancel ACC.20/WCC due to COVID-19, which was scheduled to take place March 28-30 in Chicago. However, ACC.20/WCC Virtual Meeting continues to release cutting edge science and practice changing updates for cardiovascular professionals on demand and free through June 2020.
- ENDO: 2020ENDO 2020 Annual Conference has been canceled due to COVID-19. Here are highlights of emerging data that has still been released. Keep an eye out for ENDO Online 2020, which will take place from June 8 to 22.
- CROI 2020Every year, CROI hosts some of the world's leading experts in HIV research, who come to present exciting new data and drive forward the field of HIV/AIDS research. This year, due to COVID-19, CROI held their meeting virtually.